| Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis ME Wechsler, P Akuthota, D Jayne, P Khoury, A Klion, CA Langford, ... New England Journal of Medicine 376 (20), 1921-1932, 2017 | 1129 | 2017 |
| Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes P Valent, AD Klion, HP Horny, F Roufosse, J Gotlib, PF Weller, ... Journal of Allergy and Clinical Immunology 130 (3), 607-612. e9, 2012 | 957 | 2012 |
| Expansion of the Human Phenotype Ontology (HPO) knowledge base and resources S Köhler, L Carmody, N Vasilevsky, JOB Jacobsen, D Danis, JP Gourdine, ... Nucleic acids research 47 (D1), D1018-D1027, 2019 | 790 | 2019 |
| Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy PU Ogbogu, BS Bochner, JH Butterfield, GJ Gleich, J Huss-Marp, JE Kahn, ... Journal of Allergy and Clinical Immunology 124 (6), 1319-1325. e3, 2009 | 755 | 2009 |
| Treatment of patients with the hypereosinophilic syndrome with mepolizumab ME Rothenberg, AD Klion, FE Roufosse, JE Kahn, PF Weller, HU Simon, ... New England Journal of Medicine 358 (12), 1215-1228, 2008 | 711 | 2008 |
| The role of eosinophils in host defense against helminth parasites AD Klion, TB Nutman Journal of Allergy and Clinical Immunology 113 (1), 30-37, 2004 | 607 | 2004 |
| Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor … AD Klion, P Noel, C Akin, MA Law, DG Gilliland, J Cools, DD Metcalfe, ... Blood 101 (12), 4660-4666, 2003 | 450 | 2003 |
| Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report AD Klion, BS Bochner, GJ Gleich, TB Nutman, ME Rothenberg, HU Simon, ... Journal of Allergy and Clinical Immunology 117 (6), 1292-1302, 2006 | 443 | 2006 |
| Refining the definition of hypereosinophilic syndrome HU Simon, ME Rothenberg, BS Bochner, PF Weller, AJ Wardlaw, ... Journal of allergy and clinical immunology 126 (1), 45-49, 2010 | 398 | 2010 |
| The long non-coding RNA Morrbid regulates Bim and short-lived myeloid cell lifespan JJ Kotzin, SP Spencer, SJ McCright, DBU Kumar, MA Collet, WK Mowel, ... Nature 537 (7619), 239-243, 2016 | 319 | 2016 |
| A new dawn for eosinophils in the tumour microenvironment S Grisaru-Tal, M Itan, AD Klion, A Munitz Nature Reviews Cancer 20 (10), 594-607, 2020 | 310 | 2020 |
| Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome AD Klion, J Robyn, C Akin, P Noel, M Brown, M Law, DD Metcalfe, ... Blood 103 (2), 473-478, 2004 | 294 | 2004 |
| Contributions of eosinophils to human health and disease AD Klion, SJ Ackerman, BS Bochner Annual Review of Pathology: Mechanisms of Disease 15 (1), 179-209, 2020 | 292 | 2020 |
| How I treat hypereosinophilic syndromes AD Klion Blood, The Journal of the American Society of Hematology 126 (9), 1069-1077, 2015 | 290 | 2015 |
| Anti–Siglec-8 antibody for eosinophilic gastritis and duodenitis ES Dellon, KA Peterson, JA Murray, GW Falk, N Gonsalves, M Chehade, ... New England Journal of Medicine 383 (17), 1624-1634, 2020 | 279 | 2020 |
| Long-term safety of mepolizumab for the treatment of hypereosinophilic syndromes FE Roufosse, JE Kahn, GJ Gleich, LB Schwartz, AD Singh, ... Journal of allergy and clinical immunology 131 (2), 461-467. e5, 2013 | 253 | 2013 |
| Effect of dupilumab on blood eosinophil counts in patients with asthma, chronic rhinosinusitis with nasal polyps, atopic dermatitis, or eosinophilic esophagitis ME Wechsler, AD Klion, P Paggiaro, P Nair, D Staumont-Salle, A Radwan, ... The Journal of Allergy and Clinical Immunology: In Practice 10 (10), 2695-2709, 2022 | 237 | 2022 |
| Benralizumab for PDGFRA-Negative Hypereosinophilic Syndrome FL Kuang, F Legrand, M Makiya, JA Ware, L Wetzler, T Brown, T Magee, ... New England Journal of Medicine 380 (14), 1336-1346, 2019 | 218 | 2019 |
| Efficacy and safety of mepolizumab in hypereosinophilic syndrome: a phase III, randomized, placebo-controlled trial F Roufosse, JE Kahn, ME Rothenberg, AJ Wardlaw, AD Klion, SY Kirby, ... Journal of Allergy and Clinical Immunology 146 (6), 1397-1405, 2020 | 211 | 2020 |
| Biomarkers of the involvement of mast cells, basophils and eosinophils in asthma and allergic diseases DD Metcalfe, R Pawankar, SJ Ackerman, C Akin, F Clayton, FH Falcone, ... World Allergy Organization Journal 9, 7, 2016 | 204 | 2016 |
